| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/26/2009 | US20090054467 Pyrrolo Pyrimidines as Agents for the Inhibition of Cystein Proteases |
| 02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
| 02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
| 02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
| 02/26/2009 | US20090054420 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/26/2009 | US20090054413 Novel 5,6-Dihydropyrazolo[3,4-E] [L,4]Diazepin-4 (IH) -One Derivatives for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090054381 Methods for treating respiratory disorders |
| 02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 02/26/2009 | US20090054374 Methods of treating acute exacerbations of chronic obstructive pulmonary disease |
| 02/26/2009 | US20090054360 Method and Composition for Treating Allergic Diseases |
| 02/26/2009 | US20090054357 Macrolide compounds endowed with antiinflammatory activity |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053334 Ghrelin production promoter |
| 02/26/2009 | US20090053319 Sore Throat Relief Composition And Method of Producing Same |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | CA2697081A1 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 02/26/2009 | CA2697020A1 Method of producing plant extract formulations |
| 02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027143A2 Compounds and compositions as channel activating protease inhibitors |
| 02/25/2009 | EP2027108A1 Histamine receptor antagonists comprising an azepin core |
| 02/25/2009 | EP2026775A2 Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders |
| 02/25/2009 | EP2026761A1 Inhalant propellant-free aerosol formulation |
| 02/25/2009 | EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 02/25/2009 | EP1680105B1 Use of glucosidase inhibitors for therapy of mucoviscidosis |
| 02/25/2009 | EP1474117B1 Composition for inhalation |
| 02/25/2009 | EP1240326B1 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify this receptor |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | CN201197815Y Loratadine and pseudoephedrine sulfate sustained and controlled release capsules |
| 02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
| 02/25/2009 | CN101374841A Spiro imidazole derivatives as PPAR modulators |
| 02/25/2009 | CN101374823A Organic compounds |
| 02/25/2009 | CN101374538A Pharmaceutical for promoting functional regeneration of damaged tissue |
| 02/25/2009 | CN101371905A Chinese medicine lozenge for treating throat disease |
| 02/25/2009 | CN101371892A Pollen medicine for causing vomiting |
| 02/25/2009 | CN101371871A Echinacea purpurea five-component oral spray |
| 02/25/2009 | CN101371832A Medical use of triacetyl andrographolide as proinflammatory cytokine inhibitor |
| 02/25/2009 | CN100463691C Method for preparing gel of relieving a cough |
| 02/25/2009 | CN100463684C Medicinal composition for treating coryza and preparation method thereof |
| 02/25/2009 | CN100463668C Reversibly hot gelified water soluble medicine composition |
| 02/25/2009 | CN100463611C Processing method of natural bamboo juice soy sauce |
| 02/24/2009 | US7495127 Calcium-activated potassium channel (BK channel) with opening activity equivalent to or higher than that of maxikdiol, and has high specificity; pimaric acid, dihydropimaric acid, dihydroisopimarinol, sandaracopimaric acid, isopimaric acid, and dihydroisopimaric acid |
| 02/24/2009 | US7495109 Nociceptin analogs |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495018 An enzyme inhibitor of p38 MAP kinase, an antagonist of tumor necrosis factors or adenosine receptor, a thiazole with the 5-pyridyl group derivatives |
| 02/24/2009 | US7494989 Pyridine compounds useful as N-type calcium channel antagonists |
| 02/24/2009 | US7494987 compounds with potent antitussive actions, high safety and less adverse actions; methyl 4-({1-[2-(4-cyanophenyl)ethyl]-3-hydroxyazetidin-3-ylmethyl}methylamino)benzoate |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2432085C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2418613C Spray device |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/21/2009 | CA2638999A1 Sore throat relief composition and method of producing the same |
| 02/19/2009 | WO2009023653A2 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | WO2009023509A2 Therapeutic combinations useful in treating cftr related diseases |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009021404A1 (1s, 2s, 3s, 4r)-3-[(1s)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2- hydroxyl-cyclopentyl-1-carboxylic acid hydrates and pharmaceutical uses thereof |
| 02/19/2009 | WO2008155520A3 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 02/19/2009 | WO2008144320A3 Opioid and methods of making and using the same |
| 02/19/2009 | WO2008109856A3 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048339 Compositions of cis-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof |
| 02/19/2009 | US20090048308 VLA-4 Antagonists |
| 02/19/2009 | US20090048281 Organic Compounds |
| 02/19/2009 | US20090048267 Medicaments for the treatment or prevention of fibrotic diseases |
| 02/19/2009 | US20090048260 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048220 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048175 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/19/2009 | US20090048167 Disease treatment via antimicrobial peptides or their inhibitors |
| 02/19/2009 | US20090048149 Antagonists of the bradykinin B1 receptor |
| 02/19/2009 | US20090047343 Method for stabilizing phenylephrine |
| 02/19/2009 | US20090047336 novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| 02/19/2009 | US20090047327 Sinus delivery of sustained release therapeutics |
| 02/19/2009 | US20090047326 Sinus delivery of sustained release therapeutics |
| 02/19/2009 | US20090047266 Lipases for Pharmaceutical Use |
| 02/19/2009 | US20090047264 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2696630A1 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 02/19/2009 | CA2695990A1 Saline nose wipe and methods of manufacture and use |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/18/2009 | EP2025754A2 Moraxella (Branhamella) catarrhalis antigens |
| 02/18/2009 | EP2025752A2 Antisense oligonucleotides for the inhibition of expression of type I procollagen |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025670A1 3-(Phenyl or quinolyl)thio-1H-indole-1-acetic acid derivatives as modulators of CRTh2 receptor activity |
| 02/18/2009 | EP2025338A1 New medicaments for the treatment of chronic ostructive pulmonary disease |
| 02/18/2009 | EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain |
| 02/18/2009 | EP2024367A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors |
| 02/18/2009 | EP2024329A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |